Senseonics Holdings, Inc. (NASDAQ: SENS) Stock Competitors & Peer Comparison
See SENS's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for SENS and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SENS | $8.94 | +2.88% | 380.7M | -4.55 | -$2.00 | N/A |
| ABT | $114.32 | +1.46% | 198.1B | 21.97 | $5.21 | +2.16% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| SYK | $333.66 | +0.69% | 130.4B | 25.40 | $13.39 | +1.02% |
| MDT | $92.70 | +0.66% | 120.5B | 17.02 | $5.53 | +3.03% |
| BSX | $49.93 | -1.08% | 77.3B | 16.78 | $3.10 | N/A |
| EW | $90.10 | -0.97% | 53.1B | 34.18 | $2.70 | N/A |
| DXCM | $90.24 | +0.71% | 33.9B | 38.58 | $2.33 | N/A |
| RMD | $229.59 | +4.37% | 33.5B | 21.43 | $10.77 | +1.04% |
| PHG | $27.59 | +1.79% | 27B | 15.78 | $1.75 | +3.58% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
SENS vs ABT Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, ABT has a market cap of 198.1B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while ABT trades at $114.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas ABT's P/E ratio is 21.97. In terms of profitability, SENS's ROE is -1.66%, compared to ABT's ROE of +0.11%. Regarding short-term risk, SENS is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for SENS.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
SENS vs BSX-PA Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, SENS's ROE is -1.66%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, SENS is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for SENS.Check BSX-PA's competition here
Stryker Corporation (NYSE: SYK)
SENS vs SYK Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, SYK has a market cap of 130.4B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while SYK trades at $333.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas SYK's P/E ratio is 25.40. In terms of profitability, SENS's ROE is -1.66%, compared to SYK's ROE of +0.16%. Regarding short-term risk, SENS is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for SENS.Check SYK's competition here
Medtronic plc (NYSE: MDT)
SENS vs MDT Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, MDT has a market cap of 120.5B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while MDT trades at $92.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas MDT's P/E ratio is 17.02. In terms of profitability, SENS's ROE is -1.66%, compared to MDT's ROE of +0.10%. Regarding short-term risk, SENS is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for SENS.Check MDT's competition here
Boston Scientific Corporation (NYSE: BSX)
SENS vs BSX Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, BSX has a market cap of 77.3B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while BSX trades at $49.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas BSX's P/E ratio is 16.78. In terms of profitability, SENS's ROE is -1.66%, compared to BSX's ROE of +0.15%. Regarding short-term risk, SENS is less volatile compared to BSX. This indicates lower risk in terms of short-term price fluctuations for SENS.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
SENS vs EW Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, EW has a market cap of 53.1B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while EW trades at $90.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas EW's P/E ratio is 34.18. In terms of profitability, SENS's ROE is -1.66%, compared to EW's ROE of +0.10%. Regarding short-term risk, SENS is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for SENS.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
SENS vs DXCM Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, DXCM has a market cap of 33.9B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while DXCM trades at $90.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas DXCM's P/E ratio is 38.58. In terms of profitability, SENS's ROE is -1.66%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, SENS is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for SENS.Check DXCM's competition here
ResMed Inc. (NYSE: RMD)
SENS vs RMD Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, RMD has a market cap of 33.5B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while RMD trades at $229.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas RMD's P/E ratio is 21.43. In terms of profitability, SENS's ROE is -1.66%, compared to RMD's ROE of +0.24%. Regarding short-term risk, SENS is more volatile compared to RMD. This indicates higher risk in terms of short-term price fluctuations for SENS.Check RMD's competition here
Koninklijke Philips N.V. (NYSE: PHG)
SENS vs PHG Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, PHG has a market cap of 27B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while PHG trades at $27.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas PHG's P/E ratio is 15.78. In terms of profitability, SENS's ROE is -1.66%, compared to PHG's ROE of +0.10%. Regarding short-term risk, SENS is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for SENS.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
SENS vs ZBH Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, ZBH has a market cap of 19.5B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while ZBH trades at $100.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas ZBH's P/E ratio is 11.88. In terms of profitability, SENS's ROE is -1.66%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, SENS is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for SENS.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
SENS vs ABMD Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas ABMD's P/E ratio is 65.36. In terms of profitability, SENS's ROE is -1.66%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, SENS is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for SENS.Check ABMD's competition here
Penumbra, Inc. (NYSE: PEN)
SENS vs PEN Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, PEN has a market cap of 12.9B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while PEN trades at $324.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas PEN's P/E ratio is 85.35. In terms of profitability, SENS's ROE is -1.66%, compared to PEN's ROE of +0.11%. Regarding short-term risk, SENS is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for SENS.Check PEN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
SENS vs SWAV Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas SWAV's P/E ratio is 78.76. In terms of profitability, SENS's ROE is -1.66%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, SENS is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for SENS.Check SWAV's competition here
Smith & Nephew plc (NYSE: SNN)
SENS vs SNN Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, SNN has a market cap of 12.3B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while SNN trades at $29.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas SNN's P/E ratio is 13.78. In terms of profitability, SENS's ROE is -1.66%, compared to SNN's ROE of +0.12%. Regarding short-term risk, SENS is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for SENS.Check SNN's competition here
Globus Medical, Inc. (NYSE: GMED)
SENS vs GMED Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, GMED has a market cap of 11.9B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while GMED trades at $86.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas GMED's P/E ratio is 19.91. In terms of profitability, SENS's ROE is -1.66%, compared to GMED's ROE of +0.12%. Regarding short-term risk, SENS is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for SENS.Check GMED's competition here
Align Technology, Inc. (NASDAQ: ALGN)
SENS vs ALGN Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, ALGN has a market cap of 11.7B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while ALGN trades at $158.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas ALGN's P/E ratio is 14.86. In terms of profitability, SENS's ROE is -1.66%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, SENS is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for SENS.Check ALGN's competition here
Glaukos Corporation (NYSE: GKOS)
SENS vs GKOS Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, GKOS has a market cap of 11.2B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while GKOS trades at $187.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas GKOS's P/E ratio is -220.35. In terms of profitability, SENS's ROE is -1.66%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, SENS is more volatile compared to GKOS. This indicates higher risk in terms of short-term price fluctuations for SENS.Check GKOS's competition here
Insulet Corp. (NASDAQ: PODD)
SENS vs PODD Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, PODD has a market cap of 10.5B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while PODD trades at $149.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas PODD's P/E ratio is 25.81. In terms of profitability, SENS's ROE is -1.66%, compared to PODD's ROE of +0.27%. Regarding short-term risk, SENS is more volatile compared to PODD. This indicates higher risk in terms of short-term price fluctuations for SENS.Check PODD's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
SENS vs BIO-B Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, BIO-B has a market cap of 10B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while BIO-B trades at $337.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas BIO-B's P/E ratio is 108.03. In terms of profitability, SENS's ROE is -1.66%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, SENS is less volatile compared to BIO-B. This indicates lower risk in terms of short-term price fluctuations for SENS.Check BIO-B's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
SENS vs BIO Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, BIO has a market cap of 9.8B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while BIO trades at $376.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas BIO's P/E ratio is 39.25. In terms of profitability, SENS's ROE is -1.66%, compared to BIO's ROE of +0.03%. Regarding short-term risk, SENS is less volatile compared to BIO. This indicates lower risk in terms of short-term price fluctuations for SENS.Check BIO's competition here
Masimo Corporation (NASDAQ: MASI)
SENS vs MASI Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas MASI's P/E ratio is 44.43. In terms of profitability, SENS's ROE is -1.66%, compared to MASI's ROE of +0.09%. Regarding short-term risk, SENS is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for SENS.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
SENS vs BRKR Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, BRKR has a market cap of 8.9B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while BRKR trades at $60.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas BRKR's P/E ratio is 29.47. In terms of profitability, SENS's ROE is -1.66%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, SENS is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for SENS.Check BRKR's competition here
Haemonetics Corporation (NYSE: HAE)
SENS vs HAE Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, HAE has a market cap of 4.9B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while HAE trades at $109.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas HAE's P/E ratio is 21.64. In terms of profitability, SENS's ROE is -1.66%, compared to HAE's ROE of +0.11%. Regarding short-term risk, SENS is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for SENS.Check HAE's competition here
Inari Medical, Inc. (NASDAQ: NARI)
SENS vs NARI Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas NARI's P/E ratio is -59.24. In terms of profitability, SENS's ROE is -1.66%, compared to NARI's ROE of -0.00%. Regarding short-term risk, SENS is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for SENS.Check NARI's competition here
LivaNova PLC (NASDAQ: LIVN)
SENS vs LIVN Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, LIVN has a market cap of 4.4B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while LIVN trades at $77.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas LIVN's P/E ratio is 19.20. In terms of profitability, SENS's ROE is -1.66%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, SENS is less volatile compared to LIVN. This indicates lower risk in terms of short-term price fluctuations for SENS.Check LIVN's competition here
Integer Holdings Corporation (NYSE: ITGR)
SENS vs ITGR Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while ITGR trades at $125.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas ITGR's P/E ratio is 19.73. In terms of profitability, SENS's ROE is -1.66%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, SENS is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for SENS.Check ITGR's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
SENS vs IRTC Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, IRTC has a market cap of 4.1B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while IRTC trades at $127.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas IRTC's P/E ratio is -194.92. In terms of profitability, SENS's ROE is -1.66%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, SENS is similarly volatile compared to IRTC. This indicates similar risk in terms of short-term price fluctuations for SENS.Check IRTC's competition here
Axonics, Inc. (NASDAQ: AXNX)
SENS vs AXNX Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas AXNX's P/E ratio is -709.80. In terms of profitability, SENS's ROE is -1.66%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, SENS is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for SENS.Check AXNX's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
SENS vs TMDX Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, TMDX has a market cap of 3.2B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while TMDX trades at $93.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas TMDX's P/E ratio is 47.70. In terms of profitability, SENS's ROE is -1.66%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, SENS is more volatile compared to TMDX. This indicates higher risk in terms of short-term price fluctuations for SENS.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
SENS vs AXGN Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, AXGN has a market cap of 2.6B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while AXGN trades at $45.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas AXGN's P/E ratio is 128.76. In terms of profitability, SENS's ROE is -1.66%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, SENS is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for SENS.Check AXGN's competition here
Butterfly Network, Inc. (NYSE: BFLY)
SENS vs BFLY Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, BFLY has a market cap of 2.4B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while BFLY trades at $9.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas BFLY's P/E ratio is -38.23. In terms of profitability, SENS's ROE is -1.66%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, SENS is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for SENS.Check BFLY's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
SENS vs UFPT Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, UFPT has a market cap of 2.4B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while UFPT trades at $308.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas UFPT's P/E ratio is 31.96. In terms of profitability, SENS's ROE is -1.66%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, SENS is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for SENS.Check UFPT's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
SENS vs ESTA Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, ESTA has a market cap of 2.2B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while ESTA trades at $71.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas ESTA's P/E ratio is -59.81. In terms of profitability, SENS's ROE is -1.66%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, SENS is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for SENS.Check ESTA's competition here
NuVasive, Inc. (NASDAQ: NUVA)
SENS vs NUVA Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas NUVA's P/E ratio is 75.00. In terms of profitability, SENS's ROE is -1.66%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, SENS is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for SENS.Check NUVA's competition here
Novocure Ltd (NASDAQ: NVCR)
SENS vs NVCR Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, NVCR has a market cap of 2B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while NVCR trades at $17.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas NVCR's P/E ratio is -11.27. In terms of profitability, SENS's ROE is -1.66%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, SENS is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for SENS.Check NVCR's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
SENS vs INSP Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, INSP has a market cap of 1.8B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while INSP trades at $60.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas INSP's P/E ratio is 27.23. In terms of profitability, SENS's ROE is -1.66%, compared to INSP's ROE of +0.18%. Regarding short-term risk, SENS is more volatile compared to INSP. This indicates higher risk in terms of short-term price fluctuations for SENS.Check INSP's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
SENS vs TNDM Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, TNDM has a market cap of 1.6B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while TNDM trades at $22.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas TNDM's P/E ratio is -21.33. In terms of profitability, SENS's ROE is -1.66%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, SENS is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for SENS.Check TNDM's competition here
CONMED Corporation (NYSE: CNMD)
SENS vs CNMD Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, CNMD has a market cap of 1.5B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while CNMD trades at $51.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas CNMD's P/E ratio is 11.28. In terms of profitability, SENS's ROE is -1.66%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, SENS is less volatile compared to CNMD. This indicates lower risk in terms of short-term price fluctuations for SENS.Check CNMD's competition here
Enovis Corporation (NYSE: ENOV)
SENS vs ENOV Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, ENOV has a market cap of 1.5B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while ENOV trades at $26.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas ENOV's P/E ratio is 7.59. In terms of profitability, SENS's ROE is -1.66%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, SENS is more volatile compared to ENOV. This indicates higher risk in terms of short-term price fluctuations for SENS.Check ENOV's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
SENS vs ATEC Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, ATEC has a market cap of 1.5B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while ATEC trades at $9.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas ATEC's P/E ratio is -162.50. In terms of profitability, SENS's ROE is -1.66%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, SENS is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for SENS.Check ATEC's competition here
Artivion, Inc. (NYSE: AORT)
SENS vs AORT Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, AORT has a market cap of 1.4B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while AORT trades at $28.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas AORT's P/E ratio is 48.02. In terms of profitability, SENS's ROE is -1.66%, compared to AORT's ROE of -0.01%. Regarding short-term risk, SENS is more volatile compared to AORT. This indicates higher risk in terms of short-term price fluctuations for SENS.Check AORT's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
SENS vs IART Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, IART has a market cap of 1.3B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while IART trades at $16.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas IART's P/E ratio is 7.31. In terms of profitability, SENS's ROE is -1.66%, compared to IART's ROE of -0.01%. Regarding short-term risk, SENS is more volatile compared to IART. This indicates higher risk in terms of short-term price fluctuations for SENS.Check IART's competition here
Heska Corporation (NASDAQ: HSKA)
SENS vs HSKA Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas HSKA's P/E ratio is -62.49. In terms of profitability, SENS's ROE is -1.66%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, SENS is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for SENS.Check HSKA's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
SENS vs PRCT Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, PRCT has a market cap of 1.2B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while PRCT trades at $21.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas PRCT's P/E ratio is -11.29. In terms of profitability, SENS's ROE is -1.66%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, SENS is more volatile compared to PRCT. This indicates higher risk in terms of short-term price fluctuations for SENS.Check PRCT's competition here
Avanos Medical, Inc. (NYSE: AVNS)
SENS vs AVNS Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas AVNS's P/E ratio is 27.77. In terms of profitability, SENS's ROE is -1.66%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, SENS is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for SENS.Check AVNS's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
SENS vs LMRI Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, LMRI has a market cap of 1.1B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while LMRI trades at $11.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas LMRI's P/E ratio is -23.06. In terms of profitability, SENS's ROE is -1.66%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, SENS is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for SENS.Check LMRI's competition here
IRadimed Corporation (NASDAQ: IRMD)
SENS vs IRMD Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while IRMD trades at $87.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas IRMD's P/E ratio is 43.92. In terms of profitability, SENS's ROE is -1.66%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, SENS is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for SENS.Check IRMD's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
SENS vs SILK Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas SILK's P/E ratio is -18.96. In terms of profitability, SENS's ROE is -1.66%, compared to SILK's ROE of -0.35%. Regarding short-term risk, SENS is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for SENS.Check SILK's competition here
Paragon 28, Inc. (NYSE: FNA)
SENS vs FNA Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas FNA's P/E ratio is -19.83. In terms of profitability, SENS's ROE is -1.66%, compared to FNA's ROE of -0.35%. Regarding short-term risk, SENS is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for SENS.Check FNA's competition here
Bioventus Inc. (NASDAQ: BVS)
SENS vs BVS Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, BVS has a market cap of 994.5M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while BVS trades at $14.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas BVS's P/E ratio is 19.32. In terms of profitability, SENS's ROE is -1.66%, compared to BVS's ROE of +0.28%. Regarding short-term risk, SENS is less volatile compared to BVS. This indicates lower risk in terms of short-term price fluctuations for SENS.Check BVS's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
SENS vs AVR Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, AVR has a market cap of 955.8M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while AVR trades at $9.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas AVR's P/E ratio is -4.41. In terms of profitability, SENS's ROE is -1.66%, compared to AVR's ROE of -0.78%. Regarding short-term risk, SENS is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for SENS.Check AVR's competition here
CeriBell, Inc. (NASDAQ: CBLL)
SENS vs CBLL Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, CBLL has a market cap of 944.4M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while CBLL trades at $24.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas CBLL's P/E ratio is -15.27. In terms of profitability, SENS's ROE is -1.66%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, SENS is more volatile compared to CBLL. This indicates higher risk in terms of short-term price fluctuations for SENS.Check CBLL's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
SENS vs BBNX Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, BBNX has a market cap of 900.2M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while BBNX trades at $18.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas BBNX's P/E ratio is -13.25. In terms of profitability, SENS's ROE is -1.66%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, SENS is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for SENS.Check BBNX's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
SENS vs SIBN Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, SIBN has a market cap of 883M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while SIBN trades at $19.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas SIBN's P/E ratio is -58.56. In terms of profitability, SENS's ROE is -1.66%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, SENS is more volatile compared to SIBN. This indicates higher risk in terms of short-term price fluctuations for SENS.Check SIBN's competition here
InMode Ltd. (NASDAQ: INMD)
SENS vs INMD Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, INMD has a market cap of 864.5M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while INMD trades at $14.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas INMD's P/E ratio is 10.44. In terms of profitability, SENS's ROE is -1.66%, compared to INMD's ROE of +0.12%. Regarding short-term risk, SENS is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for SENS.Check INMD's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
SENS vs CSII Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas CSII's P/E ratio is -20.83. In terms of profitability, SENS's ROE is -1.66%, compared to CSII's ROE of -0.14%. Regarding short-term risk, SENS is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for SENS.Check CSII's competition here
Varex Imaging Corporation (NASDAQ: VREX)
SENS vs VREX Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, VREX has a market cap of 777.2M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while VREX trades at $18.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas VREX's P/E ratio is 19.43. In terms of profitability, SENS's ROE is -1.66%, compared to VREX's ROE of +0.05%. Regarding short-term risk, SENS is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for SENS.Check VREX's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
SENS vs AHCO Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, AHCO has a market cap of 770.1M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while AHCO trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas AHCO's P/E ratio is 11.55. In terms of profitability, SENS's ROE is -1.66%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, SENS is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for SENS.Check AHCO's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
SENS vs SSII Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, SSII has a market cap of 720.5M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while SSII trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas SSII's P/E ratio is -70.22. In terms of profitability, SENS's ROE is -1.66%, compared to SSII's ROE of -0.27%. Regarding short-term risk, SENS is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for SENS.Check SSII's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
SENS vs KIDS Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, KIDS has a market cap of 680.7M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while KIDS trades at $26.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas KIDS's P/E ratio is -22.46. In terms of profitability, SENS's ROE is -1.66%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, SENS is more volatile compared to KIDS. This indicates higher risk in terms of short-term price fluctuations for SENS.Check KIDS's competition here
Surmodics, Inc. (NASDAQ: SRDX)
SENS vs SRDX Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas SRDX's P/E ratio is -34.66. In terms of profitability, SENS's ROE is -1.66%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, SENS is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for SENS.Check SRDX's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
SENS vs CTKB Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, CTKB has a market cap of 607M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while CTKB trades at $4.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas CTKB's P/E ratio is -24.90. In terms of profitability, SENS's ROE is -1.66%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, SENS is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for SENS.Check CTKB's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
SENS vs BWAY Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, BWAY has a market cap of 595M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while BWAY trades at $14.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas BWAY's P/E ratio is 38.54. In terms of profitability, SENS's ROE is -1.66%, compared to BWAY's ROE of +0.13%. Regarding short-term risk, SENS is more volatile compared to BWAY. This indicates higher risk in terms of short-term price fluctuations for SENS.Check BWAY's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
SENS vs DCTH Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, DCTH has a market cap of 592M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while DCTH trades at $16.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas DCTH's P/E ratio is 1715.00. In terms of profitability, SENS's ROE is -1.66%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, SENS is more volatile compared to DCTH. This indicates higher risk in terms of short-term price fluctuations for SENS.Check DCTH's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
SENS vs APEN Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas APEN's P/E ratio is -9.43. In terms of profitability, SENS's ROE is -1.66%, compared to APEN's ROE of -0.85%. Regarding short-term risk, SENS is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for SENS.Check APEN's competition here
Cerus Corporation (NASDAQ: CERS)
SENS vs CERS Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, CERS has a market cap of 574.3M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while CERS trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas CERS's P/E ratio is -56.89. In terms of profitability, SENS's ROE is -1.66%, compared to CERS's ROE of -0.10%. Regarding short-term risk, SENS is more volatile compared to CERS. This indicates higher risk in terms of short-term price fluctuations for SENS.Check CERS's competition here
ZimVie Inc. (NASDAQ: ZIMV)
SENS vs ZIMV Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, SENS's ROE is -1.66%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, SENS is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for SENS.Check ZIMV's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
SENS vs TCMD Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, TCMD has a market cap of 532.3M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while TCMD trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas TCMD's P/E ratio is 26.82. In terms of profitability, SENS's ROE is -1.66%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, SENS is less volatile compared to TCMD. This indicates lower risk in terms of short-term price fluctuations for SENS.Check TCMD's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
SENS vs NPCE Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, NPCE has a market cap of 493.3M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while NPCE trades at $13.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas NPCE's P/E ratio is -25.39. In terms of profitability, SENS's ROE is -1.66%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, SENS is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for SENS.Check NPCE's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
SENS vs CLPT Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, CLPT has a market cap of 478.6M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while CLPT trades at $15.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas CLPT's P/E ratio is -13.53. In terms of profitability, SENS's ROE is -1.66%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, SENS is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for SENS.Check CLPT's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
SENS vs SGHT Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, SGHT has a market cap of 460.9M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while SGHT trades at $8.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas SGHT's P/E ratio is -15.12. In terms of profitability, SENS's ROE is -1.66%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, SENS is more volatile compared to SGHT. This indicates higher risk in terms of short-term price fluctuations for SENS.Check SGHT's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
SENS vs OFIX Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, OFIX has a market cap of 423.6M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while OFIX trades at $10.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas OFIX's P/E ratio is -13.69. In terms of profitability, SENS's ROE is -1.66%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, SENS is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for SENS.Check OFIX's competition here
Carlsmed, Inc. (NASDAQ: CARL)
SENS vs CARL Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, CARL has a market cap of 421.9M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while CARL trades at $15.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas CARL's P/E ratio is -10.85. In terms of profitability, SENS's ROE is -1.66%, compared to CARL's ROE of -0.38%. Regarding short-term risk, SENS is less volatile compared to CARL. This indicates lower risk in terms of short-term price fluctuations for SENS.Check CARL's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
SENS vs CATX Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, CATX has a market cap of 396.9M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while CATX trades at $3.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas CATX's P/E ratio is -2.62. In terms of profitability, SENS's ROE is -1.66%, compared to CATX's ROE of -0.42%. Regarding short-term risk, SENS is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for SENS.Check CATX's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
SENS vs PACB Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, PACB has a market cap of 354.1M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while PACB trades at $1.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas PACB's P/E ratio is -2.78. In terms of profitability, SENS's ROE is -1.66%, compared to PACB's ROE of -49.62%. Regarding short-term risk, SENS is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for SENS.Check PACB's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
SENS vs TLSI Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, TLSI has a market cap of 338M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while TLSI trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas TLSI's P/E ratio is -3.27. In terms of profitability, SENS's ROE is -1.66%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, SENS is more volatile compared to TLSI. This indicates higher risk in terms of short-term price fluctuations for SENS.Check TLSI's competition here
Electromed, Inc. (AMEX: ELMD)
SENS vs ELMD Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, ELMD has a market cap of 335.8M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while ELMD trades at $39.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas ELMD's P/E ratio is 34.66. In terms of profitability, SENS's ROE is -1.66%, compared to ELMD's ROE of +0.22%. Regarding short-term risk, SENS is more volatile compared to ELMD. This indicates higher risk in terms of short-term price fluctuations for SENS.Check ELMD's competition here
Picard Medical, Inc. (AMEX: PMI)
SENS vs PMI Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, PMI has a market cap of 333.8M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while PMI trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas PMI's P/E ratio is -2.71. In terms of profitability, SENS's ROE is -1.66%, compared to PMI's ROE of +4.99%. Regarding short-term risk, SENS is less volatile compared to PMI. This indicates lower risk in terms of short-term price fluctuations for SENS.Check PMI's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
SENS vs SMLR Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas SMLR's P/E ratio is 3.92. In terms of profitability, SENS's ROE is -1.66%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, SENS is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for SENS.Check SMLR's competition here
CapsoVision, Inc. (NASDAQ: CV)
SENS vs CV Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, CV has a market cap of 305.8M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while CV trades at $6.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas CV's P/E ratio is -2.45. In terms of profitability, SENS's ROE is -1.66%, compared to CV's ROE of -1.78%. Regarding short-term risk, SENS is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for SENS.Check CV's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
SENS vs TMCI Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, TMCI has a market cap of 295.8M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while TMCI trades at $4.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas TMCI's P/E ratio is -4.85. In terms of profitability, SENS's ROE is -1.66%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, SENS is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for SENS.Check TMCI's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
SENS vs ANIK Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, ANIK has a market cap of 284.5M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while ANIK trades at $21.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas ANIK's P/E ratio is 43.39. In terms of profitability, SENS's ROE is -1.66%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, SENS is more volatile compared to ANIK. This indicates higher risk in terms of short-term price fluctuations for SENS.Check ANIK's competition here
Profound Medical Corp. (NASDAQ: PROF)
SENS vs PROF Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, PROF has a market cap of 257.3M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while PROF trades at $6.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas PROF's P/E ratio is -5.71. In terms of profitability, SENS's ROE is -1.66%, compared to PROF's ROE of -0.56%. Regarding short-term risk, SENS is more volatile compared to PROF. This indicates higher risk in terms of short-term price fluctuations for SENS.Check PROF's competition here
Avita Medical Inc. (NASDAQ: RCEL)
SENS vs RCEL Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, RCEL has a market cap of 256.9M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while RCEL trades at $10.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas RCEL's P/E ratio is -6.59. In terms of profitability, SENS's ROE is -1.66%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, SENS is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for SENS.Check RCEL's competition here
RxSight, Inc. (NASDAQ: RXST)
SENS vs RXST Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, RXST has a market cap of 255M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while RXST trades at $5.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas RXST's P/E ratio is -6.62. In terms of profitability, SENS's ROE is -1.66%, compared to RXST's ROE of -0.17%. Regarding short-term risk, SENS is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for SENS.Check RXST's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
SENS vs MGRM Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas MGRM's P/E ratio is -12.00. In terms of profitability, SENS's ROE is -1.66%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, SENS is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for SENS.Check MGRM's competition here
Nevro Corp. (NYSE: NVRO)
SENS vs NVRO Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas NVRO's P/E ratio is -1.91. In terms of profitability, SENS's ROE is -1.66%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, SENS is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for SENS.Check NVRO's competition here
Neuronetics, Inc. (NASDAQ: STIM)
SENS vs STIM Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, STIM has a market cap of 218.5M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while STIM trades at $3.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas STIM's P/E ratio is -5.81. In terms of profitability, SENS's ROE is -1.66%, compared to STIM's ROE of -1.51%. Regarding short-term risk, SENS is more volatile compared to STIM. This indicates higher risk in terms of short-term price fluctuations for SENS.Check STIM's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
SENS vs LUCD Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, LUCD has a market cap of 192.7M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while LUCD trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas LUCD's P/E ratio is -2.73. In terms of profitability, SENS's ROE is -1.66%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, SENS is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for SENS.Check LUCD's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
SENS vs BSGM Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas BSGM's P/E ratio is -5.81. In terms of profitability, SENS's ROE is -1.66%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, SENS is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for SENS.Check BSGM's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
SENS vs MDGS Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas MDGS's P/E ratio is -0.27. In terms of profitability, SENS's ROE is -1.66%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, SENS is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for SENS.Check MDGS's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
SENS vs FOCL Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, FOCL has a market cap of 163.4M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while FOCL trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas FOCL's P/E ratio is -4.21. In terms of profitability, SENS's ROE is -1.66%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, SENS is more volatile compared to FOCL. This indicates higher risk in terms of short-term price fluctuations for SENS.Check FOCL's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
SENS vs QIPT Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas QIPT's P/E ratio is -15.87. In terms of profitability, SENS's ROE is -1.66%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, SENS is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for SENS.Check QIPT's competition here
Inogen, Inc. (NASDAQ: INGN)
SENS vs INGN Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, INGN has a market cap of 153.8M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while INGN trades at $5.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas INGN's P/E ratio is -6.24. In terms of profitability, SENS's ROE is -1.66%, compared to INGN's ROE of -0.13%. Regarding short-term risk, SENS is more volatile compared to INGN. This indicates higher risk in terms of short-term price fluctuations for SENS.Check INGN's competition here
Quanterix Corporation (NASDAQ: QTRX)
SENS vs QTRX Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, QTRX has a market cap of 139.4M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while QTRX trades at $3.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas QTRX's P/E ratio is -1.17. In terms of profitability, SENS's ROE is -1.66%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, SENS is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for SENS.Check QTRX's competition here
Solana Company (NASDAQ: HSDT)
SENS vs HSDT Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, HSDT has a market cap of 108.6M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while HSDT trades at $1.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas HSDT's P/E ratio is -0.02. In terms of profitability, SENS's ROE is -1.66%, compared to HSDT's ROE of -1.23%. Regarding short-term risk, SENS is less volatile compared to HSDT. This indicates lower risk in terms of short-term price fluctuations for SENS.Check HSDT's competition here
iCAD, Inc. (NASDAQ: ICAD)
SENS vs ICAD Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas ICAD's P/E ratio is -20.37. In terms of profitability, SENS's ROE is -1.66%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, SENS is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for SENS.Check ICAD's competition here
Owlet, Inc. (NYSE: OWLT)
SENS vs OWLT Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, OWLT has a market cap of 105.3M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while OWLT trades at $5.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas OWLT's P/E ratio is -41.57. In terms of profitability, SENS's ROE is -1.66%, compared to OWLT's ROE of -0.50%. Regarding short-term risk, SENS is less volatile compared to OWLT. This indicates lower risk in terms of short-term price fluctuations for SENS.Check OWLT's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
SENS vs HJLI Comparison August 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SENS stands at 380.7M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, SENS is priced at $8.94 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SENS currently has a P/E ratio of -4.55, whereas HJLI's P/E ratio is N/A. In terms of profitability, SENS's ROE is -1.66%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, SENS is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for SENS.Check HJLI's competition here